1. Home
  2. Understanding AML-MRC and tAML
  3. Expert Video - What is secondary AML?

Expert Video - What is secondary AML?

Expert Dr. David Steensma explains that secondary acute myeloid leukemia, or secondary AML, is AML that happens in someone who has another condition, such as myelodysplastic syndrome (MDS) or another blood disorder. It can also happen in people who have certain conditions such as Down syndrome. AML-MRC and tAML are two types of secondary AML because they happen in people who already have, or had, another condition.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

Animation - Understanding AML-MRC and tAML
Animation - Understanding AML-MRC and tAML
Slide Show - Understanding AML-MRC and tAML
Slide Show - Understanding AML-MRC and tAML
Expert Videos
What is AML with myelodysplasia-related changes (AML-MRC)?
1. What is AML with myelodysplasia-related changes (AML-MRC)?
What is treatment-related AML (or tAML)?
2. What is treatment-related AML (or tAML)?
What is secondary AML?
3. What is secondary AML?
What are the symptoms of AML-MRC or tAML?
4. What are the symptoms of AML-MRC or tAML?
What are the risk factors for AML-MRC or tAML?
5. What are the risk factors for AML-MRC or tAML?
What is multilineage dysplasia?
6. What is multilineage dysplasia?
What is the outlook for AML-MRC, tAML, and secondary AML?
7. What is the outlook for AML-MRC, tAML, and secondary AML?
Patient Videos
Mike's story: How did you find out you had AML?
8. Mike's story: How did you find out you had AML?
Mike's story: What advice do you have for other patients on their journey with AML?
9. Mike's story: What advice do you have for other patients on their journey with AML?

Other Modules:

Understanding AML

Understanding AML

Understanding Erythropoiesis

Understanding Erythropoiesis

Diagnosing AML

Diagnosing AML, AML-MRC, and tAML

Treating AML

Treating AML

Treatment Failure and Relapse

Treatment Failure and Relapse in AML

Maintenance and Continuous Treatment

Maintenance and Continuous Treatment in AML

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.